Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of
Aged
Biomarkers, Tumor
/ blood
Carbon Radioisotopes
Choline
Gallium Isotopes
Gallium Radioisotopes
Humans
Lymph Node Excision
Lymphatic Metastasis
/ diagnostic imaging
Male
Membrane Glycoproteins
Middle Aged
Neoplasm Recurrence, Local
Organometallic Compounds
Positron Emission Tomography Computed Tomography
Prostate-Specific Antigen
/ blood
Prostatectomy
Prostatic Neoplasms
/ diagnostic imaging
Salvage Therapy
Tumor Burden
lymph node excision
positron-emission tomography computed tomography
prostatic neoplasms
recurrence
salvage therapy
Journal
The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
pubmed:
19
2
2020
medline:
22
9
2020
entrez:
19
2
2020
Statut:
ppublish
Résumé
We compared the use of The study included 641 patients who experienced prostate specific antigen rise and nodal recurrence after radical prostatectomy and underwent salvage lymph node dissection. Lymph node recurrence was documented by positron emission tomography/computerized tomography using Overall the extent of tumor burden underestimation was significantly higher in the Positron emission tomography/computerized tomography significantly underestimates the burden of prostate cancer recurrence, regardless of the tracer used.
Identifiants
pubmed: 32068488
doi: 10.1097/JU.0000000000000800
doi:
Substances chimiques
Biomarkers, Tumor
0
Carbon Radioisotopes
0
Gallium Isotopes
0
Gallium Radioisotopes
0
Membrane Glycoproteins
0
Organometallic Compounds
0
gallium 68 PSMA-11
0
Prostate-Specific Antigen
EC 3.4.21.77
Choline
N91BDP6H0X
Types de publication
Comparative Study
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
296-302Commentaires et corrections
Type : CommentIn
Type : CommentIn